Analog Devices (ADI) CEO sells 10K shares after exercising options under 10b5-1 plan
Rhea-AI Filing Summary
Analog Devices Chair and CEO Vincent Roche reported an option exercise and share sale. On July 1, 2026, he exercised 10,000 Non-Qualified Stock Options at $108.08 per share, acquiring the same number of common shares.
On the same date, he completed an open-market sale of 10,000 common shares at an average price of $389.75 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025. Following these transactions, Roche directly holds 137,537.875 common shares, with additional indirect holdings of 50,000 and 23,515 shares in separate Grantor Retained Annuity Trusts.
Positive
- None.
Negative
- None.
Insights
CEO exercised 10,000 options and sold 10,000 shares under a pre-set 10b5-1 plan.
Chair and CEO Vincent Roche exercised 10,000 Non-Qualified Stock Options at $108.08, then sold 10,000 common shares at $389.75. The filing shows this as an exercise-and-sell pattern, a common way to turn option awards into cash.
The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025, which typically signals a scheduled, rather than opportunistic, transaction. After the trades, he still directly owns 137,537.875 shares and holds additional shares indirectly through Grantor Retained Annuity Trusts, indicating a continuing equity stake.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $108.08 | $1.08M |
| Exercise | Comm Stock - $.16-2/3 value | 10,000 | $108.08 | $1.08M |
| Sale | Comm Stock - $.16-2/3 value | 10,000 | $389.75 | $3.90M |
| holding | Comm Stock-$.16-2/3 value | -- | -- | -- |
| holding | Comm Stock-$.16-2/3 value | -- | -- | -- |
Footnotes (1)
- These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 3, 2025. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024. Shares held by the Vincent Roche 2026 Grantor Retained Annuity Trust dated January 11, 2026. This option is fully vested.